Meredith Hirsh Meredith Hirsh

UnitedHealthcare Dropped Us From Medicare Advantage. What Does That Mean for Patient Access?

UnitedHealthcare terminated us.

Not from our entire contract, only from its Medicare Advantage network.

The Sept. 1 letter says UHC is “making changes” to its network. Effective Dec. 1, The Hirsh Center for Arthritis and Sports Medicine will be excluded from Medicare Advantage contracts while remaining in UHC’s other plans. (We are appealing this decision)

The letter identifies no quality failure or performance deficiency. Our signature is not required.

Read More
Meredith Hirsh Meredith Hirsh

Medicare Drug Savings Should Not Cost Patients Their Care

What good is a lower drug price if patients cannot find a practice that can afford to treat them? Congress can address that threat by advancing H.R. 4299.

In a congressional office last week, my heart began racing as I explained what a Medicare reimbursement change could mean for our patients.

I came prepared to discuss drug pricing. But my throat tightened as I thought about losing access to the medication that has controlled my psoriatic arthritis for eight years.

Read More
Meredith Hirsh Meredith Hirsh

UnitedHealthcare Approved Her Lupus Treatment—Then Clawed Back $15,000

UnitedHealthcare told us to proceed. 

We verified the patient’s benefits. UnitedHealthcare issued prior authorization for Benlysta. GSK’s BENLYSTA Gateway conducted a separate benefits investigation and also identified UnitedHealthcare. 

Our private rheumatology practice purchased the medication, administered five infusions, submitted the claims and received payment. 

More than a year later, UnitedHealthcare clawed back approximately $15,000.

Read More
Meredith Hirsh Meredith Hirsh

Should Health Insurance Be on Wall Street?

I am a capitalist.

I believe businesses should be able to innovate, compete, grow and earn a return on the value they create.

But health insurance is not an ordinary product. Patients cannot shop for care the way they shop for a car, a phone or a vacation. They often need care at the most vulnerable moments of their lives. In many cases, they cannot choose their insurer, cannot understand the insurer’s negotiated prices and cannot wait while two companies argue over who should pay.

I keep returning to an uncomfortable question: Would American healthcare be better without health insurers on Wall Street?

Read More
Meredith Hirsh Meredith Hirsh

IS THIS THE BEGINNING OF THE END FOR THE ACA?

For the second consecutive year, insurers are seeking double-digit premium increases for ACA marketplace plans.

But rising premiums aren’t the real story.

They’re exposing a problem that has existed since the ACA marketplace began.

Were ACA marketplace plans ever truly affordable if patients struggled to use them?

Read More
Meredith Hirsh Meredith Hirsh

Oversight Slips into Permission as Big Insurance Outplays the Federal Watchdog

The federal government loves to say it “oversees” Big Insurance.

In reality, it often supervises from a safe distance while insurers engineer aggressive workarounds in plain sight. Chris Deacon’s latest Substack piece on Anthem’s Federal Employees Health Benefits Program contract reads like a sharp case study in how power quietly shifts from the regulator to the regulated.

Read More
Meredith Hirsh Meredith Hirsh

Big Weed Is the Next Big Tobacco Hijacking Gen Z Brains

I’m watching something heartbreaking happen to Gen Z, and it’s not just on their phones.

It’s in their brains.

On my latest Working Healthcare podcast episode, “Wine, Weed and the Next Generation,” I sit down with my Zoomer son to ask why he calls high-THC cannabis “the stupid drug” of his generation — and how we are on course to destroy his entire peer group.

Read More
Meredith Hirsh Meredith Hirsh

Can Independent Rheumatology Still Win?

‍ ‍

Rheumatology hasn’t been “gobbled up” yet (Thanksgiving pun fully intended), but after reading the latest Becker's Healthcare’s analysis on physician M&A, it’s clear we’re on the menu. A handful of massive healthcare organizations are redrawing the physician landscape through aggressive acquisitions, vertical integration and high-stakes partnerships.

‍Here’s the part that should make every independent rheumatologist sit up.

‍ ‍

Read More
Meredith Hirsh Meredith Hirsh

America’s Most Expensive Broken System

We all know it — American health care costs more than any other nation. Nobody working inside the system needs another headline to prove that point. We see it in the denials, the administrative bloat, the endless billing gymnastics we perform just to keep the lights on. But it’s worth asking: why does it cost so much?

Read More
Meredith Hirsh Meredith Hirsh

2026 Medicare Part D Drug Changes You Can’t Ignore

Must-know for Medicare open enrollment: the $2,100 cap, smoothing — and the self-administered drug trap

Open enrollment runs Oct. 15 - Dec. 7. Your 2026 playbook needs three pivots that hit adherence, scheduling and cash flow.

Read More
Meredith Hirsh Meredith Hirsh

10 Rules for Entrepreneurial Success

I have owned a medical practice for over a decade, 12 years and 2 months to be precise. I have certainly made some bad decisions, but one must learn from a mistake in order to make it a learning opportunity. Fortunately, I have made more good decisions than bad ones, thus I claim success. To share my success story with others allows for me to continue to ingrain the learning opportunities I have experienced. While I am a mother, University instructor, medical practice Vice President, and business owner, I aspire to inspire and mentor my children, students, employees, colleagues and those I continue to meet along life’s journey.

Read More
Meredith Hirsh Meredith Hirsh

Denied but Not Defeated: How to Appeal an Insurance Denial—and Win

Did you know that less than 1% of denied insurance claims are appealed—but more than 50% of those that are, actually succeed? That stat alone should give every patient hope. It’s a reminder that when insurance says “no,” that doesn’t mean the fight is over. In fact, it’s often just the beginning.

Read More
Meredith Hirsh Meredith Hirsh

What COVID-19 Taught Us about Risk and Crisis Management

Risk is inevitable, but how you assess risk and manage a crisis is essential to the success of your business. Many of us are so hyper-focused on the myriad of variables associated with providing quality patient care that we forget we are in the business of healthcare.

Read More